Does XARELTO Cause Chronic obstructive pulmonary disease? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Chronic obstructive pulmonary disease have been filed in association with XARELTO. This represents 0.2% of all adverse event reports for XARELTO.
8
Reports of Chronic obstructive pulmonary disease with XARELTO
0.2%
of all XARELTO reports
0
Deaths
4
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From XARELTO?
Of the 8 reports, 4 (50.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XARELTO. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does XARELTO Cause?
Pulmonary embolism (276)
Deep vein thrombosis (234)
Drug ineffective (199)
Gastrointestinal haemorrhage (198)
Cerebrovascular accident (180)
Haemoglobin decreased (166)
Fall (124)
Anaemia (123)
Haemorrhage (121)
Cerebral haemorrhage (110)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)